期刊文献+

树突状细胞和肥大细胞对肠易激综合征作用的研究进展 被引量:1

原文传递
导出
摘要 IBS以腹痛或腹部不适伴有排便异常为主要症状,是临床常见的胃肠功能紊乱性疾病。IBS在亚洲国家的发病率为6.5%~10.1%,且呈上升趋势。1BS并非单纯的功能性胃肠病,内脏高敏感和肠道动力异常是IBS两大基本病理生理变化,潜在的机制涉及肠道免疫异常激活、肠黏膜低度炎性反应、肠道菌群改变、肠黏膜屏障功能紊乱等,各机制相互关联。
出处 《中华消化杂志》 CAS CSCD 北大核心 2015年第7期500-502,共3页 Chinese Journal of Digestion
  • 相关文献

参考文献20

  • 1Lovell RM, Ford AC. Global prevalence of and risk factors forirritable bowel syndrome: a meta-analysis [ J ]. ClinGastroenterol Hepatol, 2012,10(7) :712-721. e4.
  • 2Chang JY,Locke GR 3rd,McNally MA, et al. Impact offunctional gastrointestinal disorders on survival in thecommunity [J]. Am J Gastroenterol* 2010,105(4):822-832.
  • 3Ohman L, Simren M. Pathogenesis of IBS: role ofinflammation, immunity and neuroimmune interactions [J].Nat Rev Gastroenterol Hepatol,2010,7(3) : 163-173.
  • 4Hughes PA, Zola H, Penttila IA, et al. Immune activation inirritable bowel syndrome: can neuroimmune interactionsexplain symptoms? [J]. Am J Gastroenterol,2013, 108 ( 7):1066-1074.
  • 5Cremon C, Gargano L,Morselli-Labate AM, et al. Mucosalimmune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms[J]. Am JGastroenterol, 2009,104(2) :392-400.
  • 6Martinez C,Gonzalez-Castro A, Vicario M,et al. Cellular andmolecular basis of intestinal barrier dysfunction in the irritablebowel syndrome[J]. Gut Liver, 2012,6(3) :305-315.
  • 7Chang L,Adeyemo M,Karagiannides I, et al. Serum andcolonic mucosal immune markers in irritable bowel syndrome[J]. Am J Gastroenterol, 2012,107(2) :262*272.
  • 8Gwee KA. Post-infectious irritable bowel syndrome* aninflammation-immunological model with relevance for other IBSand functional dyspepsia [J] Neurogastroenterol Motil,2010,16(1) : 30-34.
  • 9McKernan DP,Gaszner G,Quigley EM, et al. Altered peripheraltoll-like receptor responses in the irritable bowel syndrome [J].Aliment Pharmacol Ther, 2011 ?33(9): 1045-1052.
  • 10Klooker TK,Braak B, Koopman KE, et al. The mast cellstabiliser ketotifen decreases visceral hypersensitivity andimproves intestinal symptoms in patients with irritable bowelsyndrome [J]. Gut, 2010,59(9) : 1213-1221.

二级参考文献23

  • 1李延青,张海燕,左秀丽,袁海鹏,卢雪峰,李君曼.肠易激综合征患者肠黏膜Th1/Th2漂移的研究[J].中华消化杂志,2004,24(12):728-731. 被引量:74
  • 2Chang FY, l,u CL, Chen TS. The current prevalence of irritable bowel syndrome in Asia. J Neurogastroenterol Motil, 2010, 16:389-400.
  • 3Cremon C, Gargano L, Morselli-Labate AM, et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol, 2009, 104:392-400.
  • 4Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritabIe bowel syndrome. Gastroenterology, 2007, 132 : 913-920.
  • 5Kindt S, Van Oudenhove L, Broekaert D, et al. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil, 2009, 21 : 389-398.
  • 6Plourde V, St-Pierre S, Quirion R. Calcitonin gene-related peptide in viscerosensitive response to colorectal distension in rats. Am J Physiol,1997, 273(1Pt1 ) : G191-G196.
  • 7Agostini S, Goubern M, Tondereau V, et al. A marketed fermented dairy product containing Bifidobacterium lactis CNCM 1- 2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats. Neurogastroenterol Motil,2012, 24 : e376-e172.
  • 8A1-Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology, 2000, 119: 1276-1285.
  • 9Salzmann JL, Pehier-Koch F, Bloch F, et al. Mort hometric study of colonic biopsies: a new method of estimating inflammatory diseases. Lab Invest, 1989,60:847-851.
  • 10Gwee A, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut, 1999, 44:400-406.

共引文献20

同被引文献18

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部